Dr. Robert H. Levine, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- Boston University School of Medicine (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 413
Licensed in Colorado since 1992, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: Boston University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
CO license 31631 (first issued 1992; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boulder Community Health Boulder, CO
- Adventhealth Avista Louisville, CO
Medical groups
- Boulder Medical Center, PC (86 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 413
- Services billed
- 892
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Colorectal cancer screening; colonoscopy on individual at high risk | 120 | 120 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | 75 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | 71 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 55 | 55 |
| Established patient office or other outpatient visit, 20-29 minutes | 47 | 46 |
| Biopsy of large bowel using a flexible endoscope | 43 | 43 |
| New patient office or other outpatient visit, 30-44 minutes | 40 | 40 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | 15 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sutab (sod sulf/pot chloride/mag sulf) | 189 |
| Omeprazole Other prescribers in Boulder, CO | 115 |
| Famotidine Other prescribers in Boulder, CO | 35 |
| Pantoprazole Sodium Other prescribers in Boulder, CO | 27 |
| Zenpep (lipase/protease/amylase) Other prescribers in Boulder, CO | 21 |
| Mesalamine Er (mesalamine) Other prescribers in Boulder, CO | 18 |
| Motegrity (prucalopride succinate) | 13 |
| Ursodiol Other prescribers in Boulder, CO | 13 |
| Esomeprazole Magnesium Other prescribers in Boulder, CO | 12 |
| Budesonide Dr (budesonide) Other prescribers in Boulder, CO | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 50 payments worth $1,145 in total to this clinician.
| AbbVie Inc. | $247 |
|---|---|
| Janssen Biotech, Inc. | $225 |
| Aimmune Therapeutics, Inc. | $106 |
| Regeneron Healthcare Solutions, Inc. | $69.95 |
| Braintree Laboratories, Inc. | $67.24 |
| Madrigal Pharmaceuticals | $60.42 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.35 |
| Genzyme Corporation | $55.75 |
| Food and Beverage | $1,145 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.